Literature DB >> 427322

Stabilization of lysosomes in anoxic myocardium by propranolol.

E Welman.   

Abstract

1. Isolated hearts of guinea-pigs were perfused aerobically and anoxically for 60 min. (+/-)-Propranolol was added to the perfusion medium in concentrations ranging from 10 ng to 10 microgram/ml. 2. Lysosome stability was assessed by measurements of latent acid hydrolase activity in homogenates of left ventricular tissue. 3. In the absence of propranolol, the integrity of the myocardial lysosomes was considerably reduced after 60 min anoxia. Lysosome stability was enhanced by the presence of (+/-)-propranolol. The optimal concentration was found to be 0.1 microgram/ml. This concentration of the (+)-isomer alone was less effective. 4. It was concluded that beta-adrenoceptor blockade was the major mechanism by which lysosome disruption was prevented but that some direct membrane effect of propranolol may also be involved.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 427322      PMCID: PMC1668657          DOI: 10.1111/j.1476-5381.1979.tb07854.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Properties of lysosomes in guinea pig heart: subcellular distribution and in vitro stability.

Authors:  E Welman; T J Peters
Journal:  J Mol Cell Cardiol       Date:  1976-06       Impact factor: 5.000

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Prevention of lysosome disruption in anoxic myocardium by chloroquine and methyl prednisolone.

Authors:  E Welman; T J Peters
Journal:  Pharmacol Res Commun       Date:  1977-01

4.  Influence of inotropic alteration on the severity of myocardial ischemia after experimental coronary occlusion.

Authors:  T Watanabe; F Shintani; L Fu; J Fujii; H Watanabe
Journal:  Jpn Heart J       Date:  1972-05

5.  Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs.

Authors:  K A Reimer; M M Rasmussen; R B Jennings
Journal:  Circ Res       Date:  1973-09       Impact factor: 17.367

6.  The role of glucose in the survival and 'recovery' of the anoxic isolated perfused rat heart.

Authors:  D J Hearse; E B Chain
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

7.  Altered distribution of lysosomal cathepsin D in ischemic myocardium.

Authors:  R S Decker; A R Poole; E E Griffin; J T Dingle; K Wildenthal
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

8.  Enhanced lysosome fragility in the anoxic perfused guinea pig heart: effects of glucose and mannitol.

Authors:  E Welman; T J Peters
Journal:  J Mol Cell Cardiol       Date:  1977-02       Impact factor: 5.000

Review 9.  Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.

Authors:  D G Shand
Journal:  Drugs       Date:  1974       Impact factor: 9.546

10.  Lysosomes of the arterial wall. I. Isolation and subcellular fractionation of cells from normal rabbit aorta.

Authors:  T J Peters; M Müller; C De Duve
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

View more
  3 in total

1.  Anthracyclines for acute lymphoblastic leukemia in a child with congenital long QT syndrome.

Authors:  Sachiko Sasase; Hisao Yoshida; Risa Matsumura; Emiko Miyashita; Yoshiko Hashii; Hideaki Ohta; Shu Maekawa; Shigetoyo Kogaki; Keiichi Ozono
Journal:  Int J Hematol       Date:  2011-04-22       Impact factor: 2.490

2.  Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.

Authors:  T Ogawa; N Hieda; S Sugiyama; T Ito; T Satake; T Ozawa
Journal:  Heart Vessels       Date:  1989       Impact factor: 2.037

3.  The effect of chemical sympathectomy on mitochondrial function in the ischaemic and reperfused myocardium.

Authors:  W G Nayler; E M Scott
Journal:  Br J Pharmacol       Date:  1982-12       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.